BF
KRTX

BOK Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

BOK Financial’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$316 – 1359
2023
Q4 		$316 Hold
1
– – ﹤0.01% 1202
2023
Q3 		$167 Buy
+1
New +$188 ﹤0.01% 1158

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

BOK Financial's KRTX Position: Q1 2024 in Review

BOK Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1 share — an estimated $316 sold.

BOK Financial first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $316 in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • BOK Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BOK Financial sold 1 Karuna Therapeutics, Inc. Common Stock share in Q1 2024, an estimated $316.
  • BOK Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • BOK Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $316 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on BOK Financial's 13F filing for Q1 2024, filed 15 May 2024.